Over the past few years Medidata has frequently spoken of its efforts to grow sales of its Rave electronic data capture (EDC) platform by pinching clients competitors, notably Oracle. Now, having expanded its relationship with Alcon, Medidata is looking to make inroads with Novartis.
Medidata Solutions is scheduled to close on a $287.5 million notes offering Monday, giving the company a surplus of money in the bank to finance potential acquisitions and other business activities and more than doubling the company's reserves.
Daiichi Sankyo, a Japan-based pharma heavyweight, has chosen Medidata's cloud software for the group's clinical trials in China, expanding its long-time customer relationship with the New York-based company.
Medidata Solutions grabbed record revenues of $68.1 million in the second quarter, a 27% jump from the same period a year ago. The New York City-based provider of clinical trials software showed bottom-line strength during the quarter with $8.8 million in GAAP operating income, a 55% increase from last year's second quarter.
The life sciences industry is warming up to cloud computing, or so Medidata Solutions' first quarter financial results would seem to indicate.
In a push to advance the use of genetics in personalized care for tots, Inova Translational Medicine Institute has mounted a study to correlate the genetics of young children with developmental issues.
Medidata Solutions ($MDSO) has nailed down more business from a major pharma outfit. Purdue Pharma, known for making the pain drug OxyContin, has inked a multiyear deal with Medidata, expanding use of Medidata's software for clinical trials.
In the midst of R&D cutbacks at Big Pharma companies, Medidata Solutions, which offers clinical trial management software among other electronic data capturing solutions, keeps reeling in customers--and seems to be keeping them.
Sanofi has decided to use Medidata Solutions' clinical trials software throughout the French drug giant's R&D group. The deal was one of the highlights in Medidata's third-quarter earnings report and preceded a rally of the software company's stock Wednesday.
These apps show just how broad and innovative the life science mobile world has become. Yet each is trying to solve the same critical problem--how can we make drug development more efficient? Here we present 15 mobile apps that tried to answer that question in 2012. Click here to view this slideshow >>